Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAmortizatization of IntangiblesAsset Writedowns and ImpairmentAsset Writedowns and ImpairmentCash from Financing ActivitiesCash from Financing ActivitiesCash from OperationsCash from OperationsChange in Account PayablesChange in Account PayablesChange in Accured ExpensesChange in Accured ExpensesChange in CashChange in InventoryChange in InventoryChange in ReceivablesChange in ReceivablesChange in TaxesChange in TaxesFree Cash FlowFree Cash FlowGains from Investment SecuritiesGains from Investment SecuritiesGains from Sales and DivestituresGains from Sales and DivestituresLong-Term Debt RepaymentsNet Cash FlowNet Cash FlowNet IncomeNon-cash ItemsNon-cash ItemsOther Working Capital ChangesOther Working Capital ChangesOther financing activitiesOther financing activitiesShare-based CompensationShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Journey Medical (DERM) Asset Writedowns and Impairment (2020 - 2026)

Journey Medical filings provide 6 years of Asset Writedowns and Impairment readings, the most recent being -$41000.0 for Q4 2025.

  • On a quarterly basis, Asset Writedowns and Impairment rose 86.64% to -$41000.0 in Q4 2025 year-over-year; TTM through Dec 2025 was -$211000.0, a 140.89% decrease, with the full-year FY2025 number at -$211000.0, down 140.89% from a year prior.
  • Asset Writedowns and Impairment hit -$41000.0 in Q4 2025 for Journey Medical, down from $76000.0 in the prior quarter.
  • In the past five years, Asset Writedowns and Impairment ranged from a high of $3.1 million in Q2 2023 to a low of -$2.7 million in Q4 2023.
  • Median Asset Writedowns and Impairment over the past 5 years was $62500.0 (2021), compared with a mean of $188350.0.
  • The widest YoY moves for Asset Writedowns and Impairment: up 10038.71% in 2023, down 1088.32% in 2023.
  • Journey Medical's Asset Writedowns and Impairment stood at $115000.0 in 2021, then skyrocketed by 138.26% to $274000.0 in 2022, then tumbled by 1088.32% to -$2.7 million in 2023, then skyrocketed by 88.66% to -$307000.0 in 2024, then soared by 86.64% to -$41000.0 in 2025.
  • The last three reported values for Asset Writedowns and Impairment were -$41000.0 (Q4 2025), $76000.0 (Q3 2025), and -$441000.0 (Q2 2025) per Business Quant data.